Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants
Background. KL-6 is a biomarker of interstitial lung injury and increases during repair. Aim. Our aim was to determine the predictive value of plasma KL-6 for the development of bronchopulmonary dysplasia (BPD) in preterm infants. Methods. Ninety-five extremely preterm infants (EPIs), born at <28...
Saved in:
| Main Authors: | Petya Radulova, Margaritka Boncheva, Gencho Nachev, Boriana Slancheva, Violeta Dimitrova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Critical Care Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2024/3623948 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of extremely preterm infants with bronchopulmonary dysplasia: a retrospective cohort study
by: Ashraf Gad, et al.
Published: (2025-07-01) -
Publisher Correction: Increased bronchopulmonary dysplasia along with decreased mortality in extremely preterm infants
by: Ga Won Jeon, et al.
Published: (2025-05-01) -
Enhanced vs. standard low dose dexamethasone treatment on respiratory outcomes of preterm infants with bronchopulmonary dysplasia
by: Sezgin Gunes, et al.
Published: (2025-08-01) -
Correction for ‘Point prevalence, characteristics and treatment variations for preterm infants with bronchopulmonary dysplasia in China: a ‘snapshot’ study’
Published: (2024-11-01) -
The Effects of HFOV-VG vs HFOV on Bronchopulmonary Dysplasia and Neurobehavioral Development in Preterm Infants with Perinatal Acute Respiratory Distress Syndrome
by: Tao M, et al.
Published: (2025-08-01)